These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 3099865

  • 1. The effect of pretreatment with thio-TEPA and cytosine arabinoside on megakaryocytopoiesis in rats given a sublethal dose of thio-TEPA.
    Tanum G, Sønstevold A, Engeset A.
    Blut; 1987 Jan; 54(1):33-41. PubMed ID: 3099865
    [Abstract] [Full Text] [Related]

  • 2. Megakaryocyte DNA content and platelet formation in rats after a sublethal dose of thio-TEPA.
    Tanum G.
    Exp Hematol; 1986 Mar; 14(3):202-6. PubMed ID: 3081360
    [Abstract] [Full Text] [Related]

  • 3. Metabolism and alkylating activity of thio-TEPA in rat liver slice incubation.
    Hagen B, Dale O, Neverdal G, Azri S, Nilsen OG.
    Cancer Chemother Pharmacol; 1991 Mar; 28(6):441-7. PubMed ID: 1718615
    [Abstract] [Full Text] [Related]

  • 4. Pretreatment with cytosine arabinoside does not protect against the delayed effects of irradiation on thrombopoiesis and erythropoiesis.
    Radley JM, Barber L, Hodgson GS.
    Exp Hematol; 1994 Jul; 22(7):587-92. PubMed ID: 8013575
    [Abstract] [Full Text] [Related]

  • 5. Gender aspects of liver slice incubations with N,N,N-triethylene-thiophosphamide (Thio-TEPA) in rats and mice.
    Dale O, Thommesen L, Mortensen B, Hagen B.
    Pharmacol Toxicol; 1999 Mar; 84(3):122-4. PubMed ID: 10193672
    [Abstract] [Full Text] [Related]

  • 6. A search for strain differences in response of mice to mutagenesis by thio-TEPA.
    Lyon MF, Glenister PH.
    Mutat Res; 1991 Aug; 249(2):317-21. PubMed ID: 1906579
    [Abstract] [Full Text] [Related]

  • 7. [ON HISTOCHEMICAL CHANGES IN THE KARYOCYTES OF RED BONE MARROW OF WHITE RATS FOLLOWING THE ADMINISTRATION OF THIO-TEPA].
    VERENIKINA BI.
    Tr Leningr Sanitarnogig Med Inst; 1963 Aug; 76():168-71. PubMed ID: 14103155
    [No Abstract] [Full Text] [Related]

  • 8. Phase I evaluation of thio-TEPA in combination with cisplatin for advanced gynecologic malignancies.
    Sandles LG, Freedman RS, Raber MN, Kavanagh J, Edwards CL, Scott WR, Wharton JT.
    Gynecol Oncol; 1990 Nov; 39(2):139-45. PubMed ID: 2121628
    [Abstract] [Full Text] [Related]

  • 9. Biotransformation of N,N',N''-triethylenethiophosphoramide: oxidative desulfuration to yield N,N',N''-triethylenephosphoramide associated with suicide inactivation of a phenobarbital-inducible hepatic P-450 monooxygenase.
    Ng SF, Waxman DJ.
    Cancer Res; 1990 Feb 01; 50(3):464-71. PubMed ID: 2105156
    [Abstract] [Full Text] [Related]

  • 10. Influence of scheduling on two-drug combinations of alkylating agents in vivo.
    Teicher BA, Holden SA, Jones SM, Eder JP, Herman TS.
    Cancer Chemother Pharmacol; 1989 Feb 01; 25(3):161-6. PubMed ID: 2513139
    [Abstract] [Full Text] [Related]

  • 11. The use of triethylenethiophosphoramide (Thio-TEPA) in the treatment of metastatic carcinoma of the breast.
    KUWAYTI K, HILTON JH.
    Can Med Assoc J; 1963 Mar 09; 88(10):528-9. PubMed ID: 13927682
    [Abstract] [Full Text] [Related]

  • 12. Cellular pharmacology of N,N',N''-triethylene thiophosphoramide.
    Miller B, Tenenholz T, Egorin MJ, Sosnovsky G, Rao NU, Gutierrez PL.
    Cancer Lett; 1988 Aug 15; 41(2):157-68. PubMed ID: 3135933
    [Abstract] [Full Text] [Related]

  • 13. N,N',N''-triethylenethiophosphoramide (thio-TEPA) oxygenation by constitutive hepatic P450 enzymes and modulation of drug metabolism and clearance in vivo by P450-inducing agents.
    Ng SF, Waxman DJ.
    Cancer Res; 1991 May 01; 51(9):2340-5. PubMed ID: 1707751
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of thio-TEPA and TEPA in the conventional dose-range and its correlation to myelosuppressive effects.
    Hagen B.
    Cancer Chemother Pharmacol; 1991 May 01; 27(5):373-8. PubMed ID: 1705489
    [Abstract] [Full Text] [Related]

  • 15. [The state of hemopoiesis in the regional perfusion of malignant tumors of the extremities with sarcolysin, thio-TEPA and cyclophosphane].
    Levin AO, Babinina VF.
    Vopr Onkol; 1967 May 01; 13(2):48-54. PubMed ID: 4971006
    [No Abstract] [Full Text] [Related]

  • 16. Effect of thio-tepa upon fine structures of the rat liver. 3. Effect of large doses of thio-TEPA.
    Fujimoto K.
    Kumamoto Med J; 1966 Dec 31; 19(4):198-210. PubMed ID: 4962885
    [No Abstract] [Full Text] [Related]

  • 17. Effects of thio-tepa and hydroxyurea on sperm production in Lakeview hamsters.
    Singh H, Taylor C.
    J Toxicol Environ Health; 1981 Dec 31; 8(1-2):307-16. PubMed ID: 6799658
    [Abstract] [Full Text] [Related]

  • 18. 32p-labeled thio-tepa absorption in normal rat bladders: potential guide for intravesical chemotherapy in bladder cancer.
    Puchner PJ, Veenema RJ, Tomashefsky P, Pinzus T, Tannenbaum T.
    Urology; 1974 Jul 31; 4(1):33-6. PubMed ID: 21322979
    [Abstract] [Full Text] [Related]

  • 19. The effect of intravesical thio-tepa on normal and tumor urothelium.
    Nieh PT, Daly JJ, Heaney JA, Heney NM, Prout GR.
    J Urol; 1978 Jan 31; 119(1):59-61. PubMed ID: 413937
    [Abstract] [Full Text] [Related]

  • 20. Morphologic effects of thio-TEPA on mouse urothelium.
    Murphy WM, Soloway MS, Lin CJ.
    Acta Cytol; 1977 Jan 31; 21(5):701-4. PubMed ID: 414498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.